Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease

Lancet

Volumn 348, Issue 9034, 1996, Pages 1065-1067

  Picarelli, Antonio ^a   Maiuri, Luigi ^b,c   Frate, Antonella ^a   Greco, Marco ^a   Auricchio, Salvatore ^c   Londei, Marco ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Santobono Pausilipon Children Hospital   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; ENDOMYSIUM ANTIBODY; GLIADIN;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ETIOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; JEJUNUM BIOPSY; PATHOGENESIS; PRIORITY JOURNAL; PROVOCATION TEST; SUPERNATANT; TISSUE CULTURE;

EID: 0030593837     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)03060-7     Document Type: Article

References (14)

1. 1 Marsh MN. Gluten, major histocompatility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992; 102: 330.
2. 2 Lundin KE, Scott H, Hansen T, et al. Gliadin-specific, HLA-DQ(alpha 1*0501,beta*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993; 178: 187.
3. 3 Volta U, Lenzi M, Lazzari R, et al. Antibodies to gliadin detected by immunofluorescence and a micro-ELISA method: markers of active childhood and adult coeliac disease. Gut 1985; 26: 667.
4. 4 O'Farrelly C, Kelly J, Hekkens W, et al. Alpha gliadin antibody levels: a serological test for coeliac disease. BMJ 1983; 286: 2007.
5. 5 Troncone R, Ferguson A. Anti-gliadin antibodies. J Pediatr Gastroenterol Nutr 1991; 12: 150.
6. 6 Ferreira M, Davies SL, Butler M, Scott D, Clark M, Kumar P. Endomysial antibody: is it the best screening test for coeliac disease? Gut 1992; 33: 1633.
7. 7 Marttinen A, Maki M. Purification of fibroblast-derived celiac disease autoantigen molecules. Pediatr Res 1993; 34: 420.
8. 8 Maki M, Hallstrom O, Marttinen A. Reaction of human non-collagenous polypeptides with coeliac disease autoantibodies. Lancet 1991; 338: 724.
9. 9 Maiuri L, Picarelli A, Bouvarant M, et al. Definition of the initial immunological modifications, upon in vitro gliadin challenge, in the small intestine of celiacs. Gastroenterology 1996; 110: 1368.
10. 10 Corrao G, Corazza GR, Andreani ML, et al. Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut 1994; 35: 771.
11. 11 Maki M, Holm K, Lipsanen V, et al. Serological markers and HLA genes among healthy first-degree relatives of patients with coeliac disease. Lancet 1991; 338: 1350.
12. 12 Quarantino S, Thorpe CJ, Travers PJ, Londei M. Similar antigenic surfaces, rather than sequence homology, dictates T-cell epitope molecular mimicry. Proc Natl Acad Sci USA 1995; 92: 10398.
13. 13 Franco A, Appella E, Kagnoff MF, et al. Peripheral T cell response to A-gliadin in celiac disease: differential processing and presentation capacities of Epstein-Barr-transformed B cells and fibroblasts. Clin Immunol Immunopathol 1994; 71: 75.
14. 14 Quarantio S, Feldmann M, Dayan CM, Acuto O, Londei M. Human self-reactive T cell clones expressing identical T cell receptor β chains differ in their ability to recognize a cryptic self-epitope. J Exp Med 1996; 183: 349.